相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。
Review
Allergy
Anthony P. Sunjaya et al.
Summary: This study found that the prevalence of asthma among COVID-19 patients is similar to the global prevalence of asthma. Overall findings suggest that people with asthma have a lower risk than those without asthma for acquiring COVID-19 and have similar clinical outcomes.
Article
Allergy
Lacey B. Robinson et al.
Summary: This matched cohort study found that asthma was associated with similar risks of hospitalization and mechanical ventilation, but a lower risk of mortality.
Article
Allergy
Ting Wu et al.
Summary: The study found that asthma has a low prevalence in COVID-19 cases and does not increase the risk of developing severe COVID-19. Additionally, there was no significant difference in asthma incidence across different age groups in COVID-19 infections.
Review
Allergy
Yuanyuan Wang et al.
Summary: The systematic review and meta-analysis found no significant difference in COVID-19 mortality between patients with and without asthma. There were also no differences in hospitalization duration and ICU transfer risk between asthmatic and nonasthmatic patients. However, more studies with larger sample sizes are needed to establish a conclusive conclusion on the impact of asthma on COVID-19 outcomes.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Marco Caminati et al.
Summary: Analysis of medical records of hospitalized COVID-19 asthmatic patients in Italy revealed a low prevalence of asthma, but patients with GINA 4/5 asthma and those not adequately treated may be at higher risk.
RESPIRATORY MEDICINE
(2021)
Review
Allergy
Shuang Liu et al.
Summary: The prevalence of asthma among COVID-19 patients varies widely across different countries or regions. However, asthma does not increase the risk of severe illness or poor prognosis in COVID-19 patients, and those with asthma have a lower risk of death compared to patients without asthma.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
(2021)
Review
Allergy
Natalia F. Mendes et al.
Summary: A systematic review of all reports on COVID-19 published between December 2019 and June 30, 2020 found conflicting results regarding the potential association between asthma and severe COVID-19. Only 1.6% of patients diagnosed with COVID-19 were reported to have asthma as a premorbid condition, suggesting that asthma may not be a significant contributing factor to the development of COVID-19.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY
(2021)
Article
Allergy
Lijuan Cao et al.
Summary: This study analyzed the impact of asthma on COVID-19 diagnosis, symptoms, disease severity, and cytokine profiles in patients. The results showed that patients with asthma had lower levels of interleukin-8, but asthma does not increase the severity of COVID-19 after infection.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
(2021)
Article
Respiratory System
Jose Luis Izquierdo et al.
Summary: The study analyzed clinical data of 71,182 asthma patients and found that those with COVID-19 were older, predominantly female, and had higher prevalence of comorbidities. The use of inhaled corticosteroids and biologics in asthma patients may have a protective effect against severe COVID-19 infection.
EUROPEAN RESPIRATORY JOURNAL
(2021)
Article
Critical Care Medicine
Michael C. Peters et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
(2020)
Article
Biochemistry & Molecular Biology
Markus Hoffmann et al.
Article
Allergy
Shuang Liu et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
(2020)
